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CENTER  FOR  CLINICAL  &
TRANSLATIONAL  SCIENCE
UMASS  CCTS  NEWSLETTER
UMass Medical School researchers are about to start
enrolling adolescents ages 12 through 17 in a clinical
trial to test the COVID-19 mRNA vaccine made by
Moderna . The vaccine has already been authorized for
emergency use in adults 18 years or older by the U .S .
Food and Drug Administration . This is the first it is
being tested in a younger population .Moderna expects
to enroll 3 ,000 adolescents at up to 15 sites
nationwide . Enrollment in the trial , called TeenCove , is
expected to start at the Medical School in early
February . 




CCTS  IN  THE  NEWS
UMASS  MEDICAL  SCHOOL  RESEARCHERS  TO  START
TRIAL  OF  MODERNA  COVID-19  VACCINE  IN  TEENS
BY  SUSAN  E .W .  SPENCER ,   JANUARY  26 ,  2021
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Adolescents and their families can visit the
TeenCOVEStudy.com website for more information and to
indicate their interest in participating.
EVENTS
We are pleased to announce a COVID19 mini research symposium April 9th 10-noon
to highlight the exciting COVID-19 work happening at UMASS Medical School. Back
in the spring of 2020, many of our faculty and trainees pivoted to work on Sars-
CoV2 and COVID-19. The UMASS Medical School COVID-19 Pandemic Research Fund,
the CTSA and the Worcester Foundation supported 22 pilot projects across our
campus. Please mark your calendars for a 2 hr symposium where highlights of this
work will be presented. Speakers include Robert Finberg, MD, Jeremy Luban, PhD,
Anastasia Khvorova, PhD as well as many Pilot grant recipients.
If you are interested in presenting a short overview of your COVID19 related
research please contact Kate Fitzgerald at kate.fitzgerald@umassmed.edu.
UMCCTS COVID-19 MINI-SYMPOSIUM
APRIL  9 ,  2021  10 :00  AM- NOON  
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CCTS  IN  THE  NEWS
“Children’s responses to vaccines can differ from those in
adults,” said principal investigator Katherine Luzuriaga, MD, 
the UMass Memorial Health Care Chair in Biomedical Research; vice provost for
clinical and translational research; professor of molecular medicine, pediatrics and
medicine; and director of the UMass Center for Clinical and Translational Science.
“The goals of the trial are to evaluate the safety profile of the vaccine, to see
whether adolescents make the same level of immune responses that were observed
in adults and to see whether the vaccine protects against illness or infection.”To
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New understanding and/or diagnosis of a disease process
New devices, therapeutics, and vaccines for the treatment and/or prevention
of disease
New standards of care in the practice of community medicine
New approaches to community-based research demonstrating true bi-
directionality between community and academia
New methodologies to leverage institutional strengths and 
The pursuit of high-risk, high reward studies
The UMCCTS and Worcester Polytechnic Institute (WPI) are announcing the next
funding round for the Pilot Project Program (PPP). Individual project awards (up
to $50,000 for 1 year) will be made on a competitive basis to enable investigators
to accelerate the translation of innovative discoveries into:
3
new initiatives
For more information visit:  https ://umassmed .edu/ccts/funding/PPP/
UMCCTS PILOT PROJECT PROGRAM (PPP) 2021 - 
REQUEST FOR LETTERS OF INTENT DUE  FEBRUARY  12 ,  2021  BY  5PM
FUNDING
Drug Development Collaboratory: The purpose of this Funding Opportunity
Announcement (FOA) is to support intramural-extramural collaborations on
late-stage translational science projects between NCATS Therapeutic Development
Branch (TDB) and extramural researchers, for therapeutic development of small
molecules, biologics, or gene therapies. The UG3 phase will provide support for late
stage pre-clinical work and clinical trial planning that is conducted applicant
institutions. The goal of any collaboration with TDB is to enable an IND application
by the end of the UG3 phase. If UG3 milestones are met and an IND is cleared,
support may be provided for an early stage clinical trials in the UH3 phase that will
be conducted at the applicant institutions. Application due date:  February 9, 2021
For more information visit: https://grants.nih.gov/grants/guide/pa-files/PAR-20-301.html
DRUG DEVELOPMENT COLLABORATORY: 
DUE  FEBRUARY  9 ,  2021
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Please cite the NIH CTSA award any time you use The UMMS Center for
Clinical and Translational Science resources, services and facilities or
received funding through the Center. “The project described is
supported by the National Center for Advancing Translational Sciences,
National Institutes of Health, through Grant UL1 TR001453, (or TL1
TR001454, or KL2 TR001455, as appropriate). The content is solely the
responsibility of the authors and does not necessarily represent the
official views of the NIH.”
CITE  & SUBMIT
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FUNDING
Clinical Repurposing Research to Impact Veterans: up to $50,000 to a U.S.-based
institution for a repurposing clinical trial in any disease area impacting veterans,
including mental health, PTSD and brain injuries. Proposal submissions due
February 26, 2021.  For more information visit: 
 https://www.cureswithinreach.org/programs/funding-opportunities-rfps/
CURES WITHIN REACH- CLINICAL REPURPOSING 
RESEARCH TO IMPACT VETERANS:    DUE  FEBRUARY  26 ,  2021
NCATS invites innovators and multi-expert teams to participate in the
NCATS ASPIRE Reduction-to-Practice Challenge. The goal is the
development of a platform that scientists can use to advance their
translational science relevant to development and testing of new and
safer treatments of pain, opioid use disorder and overdose. NCATS
anticipates that this integrated platform ultimately can be generalized
to address many of the roadblocks in automated chemistry. Stage 1 of
the Reduction-to-Practice Challenge opens Nov. 30, 2020, and
submissions are due by Feb. 28, 2021, at 5p.m. EST. For more information
visit: https://ncats.nih.gov/aspire/2020Challenge
NCATS ASPIRE:  REDUCTION-TO-PRACTICE CHALLENGE  
OPENS  11/30  & DUE  FEB .  28 ,  2021  AT  5  PM
The purpose of this interagency program solicitation is to support the
development of transformative high-risk, high-reward advances in computer and
information science, engineering, mathematics, statistics, behavioral and/or
cognitive research to address pressing questions in the biomedical and public
health communities.  Transformations hinge on scientific and engineering
innovations by interdisciplinary teams that develop novel methods to intuitively
and intelligently collect, sense, connect, analyze and interpret data from
individuals, devices and systems to enable discovery and optimize health.
Solutions to these complex biomedical or public health problems demand the
formation of interdisciplinary teams that are ready to address these issues, while
advancing fundamental science and engineering. Application due date: February
16, 2021.  For more information visit:
https://www.nsf.gov/pubs/2021/nsf21530/nsf21530.htm
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SMART HEALTH & BIOMEDICAL RESEARCH IN THE ERA OF
ARTIFICIAL INTELLIGENCE & ADVANCED DATA SCIENCE (SCH):
DUE  FEB .  16 ,  2021  AT  5  PM
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The Center for Advancing Point of Care Technologies (CAPCaT) is excited to share
the news that our 2021 Pilot Funding Competition has opened! Our grant awards
are for up to $100,000 of direct costs (+ indirect costs) over one year. Visit the
Solicitations page on our website for more information
https://cimit.net/web/capcat/solicitations.
 
CAPCaT is a UMass Medical School/UMass Lowell joint project funded by the
National Institutes of Health and is specifically established to advance point of care
technologies (POCT) for heart, blood, lung and sleep disorders. For more
information about us, please visit our website, https://cimit.net/web/capcat/home.  
If you have any questions, please feel free to contact CAPCaT’s project coordinator,
anne.davenport@umassmed.edu.
THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES
(CAPCAT) 2021 PILOT FUNDING: DUE  MARCH  1 ,  2021  BY  5  PM
CureAccelerator Live! for Pediatric Rare Diseases: up to $50,000 for a repurposing
clinical trial in any pediatric rare disease. Proposal submissions due March 17, 2021.
For more information visit:  https://www.cureswithinreach.org/programs/funding-
opportunities-rfps/
CURES WITHIN REACH- CURE ACCELERATOR LIVE!: 
DUE  MARCH  17 ,  2021
FUNDING
U M A S S  C C T S  N E W S L E T T E R
We are seeking to hire a postdoctoral fellow to join our efforts in developing,
managing, and translating the institution’s research portfolio.  This is a full-time
training position intended to prepare a scientist interested in moving into business
development, intellectual property, preclinical therapeutic development, academic
administration, policy, or similar career paths. The postdoctoral fellow will
contribute to or be responsible for a range of projects within the UMCCTS related to
our NIH Clinical and Translational Science Award (CTSA) grant.  The individual will
report to the Executive Vice Chancellor for Innovation and Business Development




UMASS CENTER FOR CLINICAL & TRANSLATIONAL SCIENCE (UMCCTS)
& THE BUSINESS DEVELOPMENT & INNOVATION OFFICE (BDI)
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EDUCATION
The NCI-funded PRACCTIS program (Prevention and Control of Cancer:
Training for Change in Individuals and Systems) at UMMS is now accepting
applications for postdoctoral scholars to start January 2021 and August 2021.
We train independent researchers to address critical prevention and control
care delivery issues across the cancer continuum, including primary prevention,
screening, diagnosis, treatment and survivorship, with emphasis on promoting
change in individuals, providers and systems. Our faculty mentors are leaders
in implementation science, health equity and low resource settings, health
behavior change, health informatics, systems change and health policy, health
communications, population health sciences, and prevention and intervention
research. Applicants must plan to pursue an independent research career focused
on cancer prevention and control, have earned a doctoral degree (PhD, ScD, MD,
DO, etc.), and be a U.S. citizen or permanent resident. For more information contact
Barbara Estabrook, Barbara.estabrook@umasmed.edu
POSTDOCTORAL TRAINING IN CANCER 
PREVENTION & CONTROL
The Translational Science Interagency Fellowship (TSIF) is a new post doctoral
fellowship opportunity developed by the National Center for Advancing
Translational Sciences (NCATS) and the U.S. Food and Drug Administration
(FDA).Fellows will be jointly mentored by NCATS and FDA scientists on a research
project of mutual interest to both organizations. Fellows in this program will
develop skills of value to future careers in academia, the pharmaceutical industry
and government.  Applicants must be US citizens or permanent residents and have
two years or less of postdoctoral training. More information about potential projects,
mentors, and the application process can be found at https://ncats.nih.gov/training-
education/training/TSIF .  Questions about the fellowship and application process
are welcome. Please contact TSIFellowship@nih.gov (link sends e-mail)
TRANSLATIONAL SCIENCE INTERAGENCY FELLOWSHIP
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Tufts CTSI Clinical Research Network is hosting the “Research with Sexual and
Gender Minority Populations” training module which will be led by Tania D. Strout,
PhD, RN, MS from Maine Medical Center.  Please register at:
https://ilearn.tuftsctsi.org/product?catalog=ST109_2019_Online
RESEARCH WITH SEXUAL & GENDER MINORITY POPULATIONS
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SHARE YOUR SUCCESS STORY!
Have you had your research published that cites
the UMass Center for Clinical and Translational
Science?  Has your patent been filed on technology
developed using Center funding or resources? Did
your pilot project receive external grant funding?
Share it with us at ccts@umassmed.edu. Sharing
your success demonstrates the importance and
effect of the Center for Clinical and Translational
Science at UMass.
CENTER  FOR  CLINICAL  &
TRANSLATIONAL  SCIENCE
UMASS  CCTS  NEWS  LETTER
To be included in the CCTS Monthly Newsletter , please send announcements ,
including a link , to ccts@umassmed .edu . The newsletter is published the first
week of each month .
NEWSLETTER  SUBMISSIONS
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UNIVERSITY  OF  MASSACHUSETTS  CENTER  FOR  CLINICAL  AND  TRANSLATIONAL  SCIENCE
 55  LAKE  AVENUE  N ,  WORCESTER  MA  01655
KATHERINE LUZURIAGA, MD
PI  AND  DIRECTOR ,  UMCCTS  
TERENCE R. FLOTTE, MD   
 CO-DIRECTOR ,  UMCCTS
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